Limited access to health care in patients with atypical parkinsonism during COVID-19 era may lead to higher mortality.

Salari, Mehri; Tehrani-Fateh, Sepand; Aminzade, Zahra; Etemadifar, Masoud

Salari, Mehri; Tehrani-Fateh, Sepand; Aminzade, Zahra; Etemadifar, Masoud.

Afiliação

Salari M; Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Tehrani-Fateh S; Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Aminzade Z; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Etemadifar M; Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Curr J Neurol ; 21(4): 256-258, 2022 Oct 07.

Article em En | MEDLINE | ID: mdl-38011343

Palavras-chave

COVID-19; Mortality; Parkinsonian Disorders

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Curr J Neurol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google